Miracle LS

Language: Spanish
References: 13
Page: 229-231
PDF size: 125.77 Kb.

ABSTRACT

Background: The percutaneous ethanol injection therapy (PEIT) has been used for more than 15 years in the treatment of both benign and malignant thyroid lesions. We are not aware of PEIT reports in Latin America. Methods: We present eight procedures of PEIT in hyperfunctioning solid thyroid nodules. All patients previously underwent an ultrasound-guided fine needle aspiration biopsy (FNAB); all nodules were reported as Class II of the Bethesda system. The PEIT was performed under ultrasound guidance and 99.57% ethanol was used in all procedures. The total volume injected was one cm³ per cm³ of thyroid volume, divided in three to five sessions. Results: Total remission was achieved in six people (75%) and partial remission in two (25%). All of them reported mild to moderate pain in the PEIT site that lasted between 36 and 48 hours and did not make the patients abandon their treatments. Conclusions: Our first report shows PEIT to be an efficacious procedure. We believe that PEIT is a safe and underused alternative to surgery and RAI in people with solid thyroid hyperfunctioning adenomas.

REFERENCES

1. Yasuda K, Ozaki O, Sugino K et al. Treatment of cystic lesions of the thyroid by ethanol instillation. World J Surg. 1992; 16: 958-961.

2. Verde G, Papini E, Pacxella C et al. Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf). 1994; 41: 719-724.

3. Bennedbaek FN, Karstrup S, Hegedüs L. Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol. 1997; 136: 240-250.

4. Livraghi T, Ferrari C, Bergonzi M et al. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Radiology. 1990; 175: 827-829.

5. Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol. 2011; 12 (5): 525-540.

6. Kim YJ, Baek JH, Ha EJ, Lim HK, Lee JH, Sung JY et al. Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors. Eur Radiol. 2012; 22 (7): 1573-1578.

7. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM et al; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists’ medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002; 8 (6): 457-469.

8. Cibas ES, Ali SZ; NCI Thyroid FNA State of the Science Conference. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009; 132: 658-665.

9. Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008; 18: 1244-1250.

10. Baek JH, Kim YS, Lee D, Huh JY, Lee JH. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol. 2010; 194: 1137-1142.

11. Sung JY, Kim YS, Choi H, Lee JH, Baek JH. Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? AJR Am J Roentgenol. 2011; 196: W210-W214.

12. Baek JH, Moon WJ, Kim YS, Lee JH, Lee D. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg. 2009; 33: 1971-1977.

13. Baek JH, Kim YS, Lee D, Huh JY, Lee JH. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol. 2010; 194: 1137-1142.